发明名称 Treatment of macrophage mediated disease
摘要 The invention relates to a method of treating or monitoring/diagnosing a disease state mediated by activated macrophages. The method comprises the step of administering to a patient suffering from a macrophage mediated disease state an effective amount of a composition comprising a conjugate or complex of the general formula Ab-X where the group Ab comprises a ligand capable of binding to activated macrophages, and when the conjugate is being used for treatment of the disease state, the group X comprises an immunogen, a cytotoxin, or a compound capable of altering macrophage function, and when the conjugate is being used for monitoring/diagnosing the disease state, X comprises an imaging agent. The method is useful for treating a patient suffering from a disease selected from the group consisting of rheumatoid arthritis, ulcerative colitis, Crohn's disease, inflammation, infections, osteomyelitis, atherosclerosis, organ transplant rejection, pulmonary fibrosis, sarcoidosis, and systemic sclerosis.
申请公布号 US7740854(B2) 申请公布日期 2010.06.22
申请号 US20020138275 申请日期 2002.05.02
申请人 PURDUE RESEARCH FOUNDATION 发明人 LOW PHILIP S.;TURK MARY JO
分类号 A61K39/00;G01R33/28;A61B5/055;A61K9/127;A61K39/38;A61K39/385;A61K39/395;A61K45/00;A61K47/48;A61K49/00;A61K51/00;A61K51/10;A61P1/04;A61P9/10;A61P11/00;A61P17/00;A61P19/02;A61P25/00;A61P29/00;A61P31/04;A61P37/06 主分类号 A61K39/00
代理机构 代理人
主权项
地址